Acute Influence of Resveratrol Supplementation and Beet Extract in Recovery After Exercise in Coronary Paths
1 other identifier
interventional
17
1 country
1
Brief Summary
Introduction: Most cardiovascular diseases (CVD) can be prevented and controlled by adopting lifestyle changes, such as regular physical exercise and nutrition. Resveratrol and beverage extract promote beneficial health effects due to their nutritional properties. Objective: to analyze the effects of resveratrol supplementation and withdrawal extract on post-exercise recovery in coronary heart disease patients. Methods: men diagnosed with ischemic coronary artery disease will undergo four exercise protocols consisting of 30 minutes of aerobic exercise on an ergometric treadmill, with 5 minutes of warm-up, intensity of 30% of the heart rate reserve (HRR), followed by 25 minutes at intensity 60% of FCR and for a final 30 minutes of recovery in the supine position. Before each exercise protocol, all volunteers will consume: 500 mg of placebo (starch), or 500 mg of beetroot, or 500 mg of resveratrol and will also consume resveratrol and drink (500 mg each) 30 minutes before exercise. , the order of each supplementation will be done randomly. Cardiorespiratory parameters and heart rate variability (HRV) will be assessed at different times throughout the experimental procedure. To analyze the moments (rest versus recovery), the Bonferroni post-test will be used for parametric distribution or the Dunn post-test for non-parametric distribution. Statistical significance will be calculated at 5% for all analyses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable coronary-artery-disease
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedFirst Submitted
Initial submission to the registry
October 4, 2023
CompletedFirst Posted
Study publicly available on registry
October 23, 2023
CompletedOctober 23, 2023
October 1, 2023
10 months
October 4, 2023
October 18, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Heart rate variability (HRV)
Time and frequency domain of HRV
through study completion, an average of 1 hour
Secondary Outcomes (1)
Blood Pressure
through study completion, an average of 1 hour
Study Arms (4)
Placebo Protocol
PLACEBO COMPARATORexercise and placebo capsules 500 mg (starch)
Protocol Beet
EXPERIMENTALexercise and beet extract 500 mg
Protocol Resveratrol
EXPERIMENTALexercise and resveratrol capsules 500 mg
Protocol Beet and Resveratrol
EXPERIMENTALexercise and beet extract 500mg and resveratrol capsules 500 mg
Interventions
ingestion of 500 mg of starch following 30 minutes of exercise (treadmill)
ingestion of 500 mg of beet extect following 30 minutes of exercise (treadmill)
ingestion of 500 mg of resveratrol following 30 minutes of exercise (treadmill)
ingestion 500 mg of beet extect and 500 mg of resveratrol following 30 minutes of exercise (treadmill)
Eligibility Criteria
You may qualify if:
- adult men over 45 years of age
- diagnosed with ischemic coronary artery disease and with preserved left ventricular function (above 50%), confirmed by a previous echocardiogram
You may not qualify if:
- Volunteers who present at least one of the following characteristics will be excluded:
- smokers
- alcohol drinkers
- those who did not attend a cardiovascular rehabilitation program for at least 3 months prior to data collection
- individuals who have known infections, metabolic and respiratory diseases that could interfere in cardiac autonomic control, unstable angina, uncontrolled hypertension, significant valvular disease, uncontrolled metabolic disease (e.g., uncontrolled diabetes and thyroid disease)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Estadual Paulista
Presidente Prudente, São Paulo, 19060-900, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
October 4, 2023
First Posted
October 23, 2023
Study Start
March 10, 2022
Primary Completion
January 10, 2023
Study Completion
September 30, 2023
Last Updated
October 23, 2023
Record last verified: 2023-10